Dylan A. Farnsworth

675 West 10th Avenue
Vancouver, BC V5Z1L3, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability.

ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability.

Journal: Cellular and molecular life sciences : CMLS

Published: October 22, 2025

Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Journal: Oncogene

Published: December 05, 2024

Extracellular Vesicles from Lung Adenocarcinoma Cells Induce Activation of Different Cancer-Associated Fibroblast Subtypes.

Extracellular Vesicles from Lung Adenocarcinoma Cells Induce Activation of Different Cancer-Associated Fibroblast Subtypes.

Journal: Biomedicines

Published: September 28, 2024

Characterizing the secretome of EGFR mutant lung adenocarcinoma.

Characterizing the secretome of EGFR mutant lung adenocarcinoma.

Journal: Frontiers in oncology

Published: August 31, 2023

MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.

MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.

Journal: NPJ precision oncology

Published: May 04, 2022

Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer.

Emerging Molecular Dependencies of Mutant EGFR-Driven Non-Small Cell Lung Cancer.

Journal: Cells

Published: November 09, 2021

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.

Journal: Cell reports

Published: August 17, 2021

Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.

Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.

Journal: eLife

Published: January 13, 2021

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.

Journal: Cancer research

Published: December 05, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026